Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycogenolysis-Induced Astrocytic Serping1 Expression Regulates Neuroinflammatory Effects on Hippocampal neuron. | Mol Neurobiol | 2025 | 38985256 | PubTator, text mining | PubMed |
| Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and N-acylethanolamines in patients with hereditary angioedema due to FXII mutation. | Allergy | 2025 | 38935036 | PubTator, text mining | PubMed |
| Plasma proteome fingerprint in kidney diseases. | Front Mol Biosci | 2024 | 39896931 | PubTator, text mining | PubMed |
| Patterns of C1-Inhibitor Plasma Levels and Kinin-Kallikrein System Activation in Relation to COVID-19 Severity. | Life (Basel) | 2024 | 39768234 | PubTator, text mining | PubMed |
| Urinary Immune Complexes Reflect Renal Pathology in Lupus Nephritis. | Diagnostics (Basel) | 2024 | 39767148 | PubTator, text mining | PubMed |
| [Hereditary angioedema type 1, limitations for prophylactic therapy with Lanadelumab: Regarding a case]. | Rev Alerg Mex | 2024 | 39752269 | PubTator, text mining | PubMed |
| Regulation of epidermal barrier function and pathogenesis of psoriasis by serine protease inhibitors. | Front Immunol | 2024 | 39737188 | PubTator, text mining | PubMed |
| Managing Hereditary Angioedema in a Three-Generation Family: Danazol's Promise in Resource-Limited Settings. | Cureus | 2024 | 39726446 | PubTator, text mining | PubMed |
| Phenotypic and molecular characterization of the largest worldwide cluster of hereditary angioedema type 1. | PLoS One | 2024 | 39724085 | PubTator, text mining | PubMed |
| Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers. | Int J Mol Sci | 2024 | 39684225 | PubTator, text mining | PubMed |
| Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson's model. | Transl Neurodegener | 2024 | 39681872 | PubTator, text mining | PubMed |
| Hereditary angioedema in children: Review and practical perspective for clinical management. | Pediatr Allergy Immunol | 2024 | 39655944 | PubTator, text mining | PubMed |
| Africanized honeybee venom (Apis mellifera) promotes human complement activation split products storm. | Front Immunol | 2024 | 39606222 | PubTator, text mining | PubMed |
| Hereditary angioedema (HAE) in children and adolescents: New treatment options. | Allergol Select | 2024 | 39502954 | PubTator, text mining | PubMed |
| Gene expression profiles of neuroinflammatory responses in broad brain regions in rats repeatedly administered with N-methyl-N-nitrosourea for 28 days. | J Toxicol Sci | 2024 | 39496385 | PubTator, text mining | PubMed |
| Absolute Quantitative Targeted Monitoring of Potential Plasma Protein Biomarkers: A Pilot Study on Healthy Individuals. | Biomedicines | 2024 | 39457715 | PubTator, text mining | PubMed |
| Application of a risk score model based on glycosylation-related genes in the prognosis and treatment of patients with low-grade glioma. | Front Immunol | 2024 | 39445005 | PubTator, text mining | PubMed |
| Novel prognostic model of complement and coagulation cascade-related genes correlates with immune environment and drug sensitivity in hepatocellular carcinoma. | Heliyon | 2024 | 39391504 | PubTator, text mining | PubMed |
| Hereditary Angioedema in Pregnancy Complicated by Upper Extremity Deep Venous Thrombosis: A Case Report. | Cureus | 2024 | 39371747 | PubTator, text mining | PubMed |
| Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort. | J Allergy Clin Immunol Pract | 2024 | 39357560 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=13